DRUG SUMMARY

NAME OF DRUG GENERIC (BRAND)

Rifampicin 150 mg, INH 75 mg, pyrazinamide 400 mg, ethambutol HCl 275 mg (Quadtab)

DATE ORDERE D 7/11/11

CLASSIFIC ATION

DOSE, FREQUENCY, ROUTE 2 tabs, OD ac, PO

MECHANISM OF ACTION

SPECIFIC INDICATION

SIDE EFFECTS

NURSING IMPLICATION

AntiTuberculo sis

Rifampicin, isoniazid, pyrazinamide, and ethambutol, at therapeutic levels, have demonstrated bactericidal activity against both intracellular and extracellular Mycobact erium tuberculosisorganism.

Intensive phase treatment of all forms of pulmonary & extrapulmonary tuberculosis.

CONTRAINDICATIO NS: Hypersensitivity to rifampicin, isoniazid, pyrazinamide and ethambutol HCl, or any of the components of Quadtab. Patients with severe hepatic damage and acute gout. Preexisting optic neuritis from any cause.

Rifampicin: Flu-like syndrome; hematopoietic reactions; cutaneous, GI & hepatic reactions; shortness of breath; shock & renal failure. Hypersensitivity reactions. INH: Disturbances of hepatic function, convulsions, optic neuritis & atrophy, memory impairment, toxic psychosis, hepatitis & peripheral neuropathy. Pyrazinamide: Hyperuricemia. Ethambutol: Decreased visual acuity due to optic neuritis; joint pain, anaphylactoid reactions, dermatitis, pruritus, anorexia, nausea, vomiting, abdominal pain, fever, GI upset, malaise, headache, dizziness, mental confusion, disorientation, hallucinations.

- Observe for the 10 R of drug administration - Provide adequate information about the drug - Assess for any possible drug interaction - Assess for any condition which requires precaution or contraindicatio n - Administer drug before meal to prevent reduction in drug efficacy - Instruct the pt to report any discomfort after taking the drug - Instruct the pt to rest after taking the drug

DRUG SUMMARY
NAME OF DRUG GENERIC (BRAND)
Buclizine HCl 25 mg (Propan with Iron)

DATE ORDERE D 7/16/11

CLASSIFIC ATION

DOSE, FREQUENCY, ROUTE 1 cap, OD, PO

MECHANISM OF ACTION

SPECIFIC INDICATION

SIDE EFFECTS

NURSING IMPLICATION

Appetite Stimulant

Acts as a coenzyme or a catalyst in metabolic processes.

For all types of anorexia specificall y in conditions associated w/ irritability, body weakness & easy fatigability, infection & trauma as seen in TB, Fedeficiency anemia, an orexia nervosa & malnutritio n. CONTRAINDICATIO NS: Alcohol & CNS depressants, pregnancy.

Mild drowsiness. Occasional GI discomfort.

- Observe for the 10 R of drug administration - Provide adequate information about the drug - Assess for any possible drug interaction - Assess for any condition which requires precaution or contraindicatio n - Administer drug before meal to prevent reduction in drug efficacy - Instruct the pt to report any discomfort after taking the drug - Instruct the pt to rest after taking the drug